Falk Gastro Info 2/2018

Video

Video course abdominal ultrasound
Examination of the Liver: Liver surface, examination with high frequency transducer

Author: Prof. Dr. Christoph F. Dietrich, Caritas Krankenhaus Bad Mergentheim.
©2017 Falk Foundation e.V., Freiburg. All rights reserved.

 

Please switch on your loudspeakers!

 

Link to Falk Mediacenter

 

 

Latest research in brief:

 

Bowel

Text:

Kao D et al, JAMA. 2017;318(20):1985-93

Fecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection: FMT via oral capsules was not inferior to delivery by colonoscopy in a randomized trial.

Link to text

 

Text:

Domènech E et al, Inflamm Bowel Dis. 2017;23(10):1840-6

Incidence and management of postoperative recurrence of Crohn’s disease: Spanish “real-life” study indicates that up to one third of patients do not receive preventive medical therapy following ileocecal resection and that almost half of the patients were not endoscopically monitored as recommended.

Link to text

 

Text:

Dubé C et al, Am J Gastroenterol. 2017;112(12):1790-801

Risk of advanced adenoma (AA) and colorectal cancer (CRC) in people with low-risk adenomas (LRA) at baseline colonoscopy: There is a small but significantly increased risk of AA in people with LRA compared to people with normal baseline colonoscopy. However, compared to the general population, people with LRA have significantly lower risks of CRC and CRC-related mortality.

Link to text

 

Liver Biliary Tracts

Text:

Yip TCF et al, J Hepatol. 2018;68(1):63-72

Chronic hepatitis B: According to a recent study, nucleos(t)id analogue-induced hepatitis B surface antigen (HBsAg) seroclearance is as durable as spontaneous HBsAg seroclearance. A positive hepatitis B surface antibody (anti-HBs) is not required before stopping treatment, however, an antiviral consolidation treatment for at least 12 months may result in more durable HBsAg seroclearance.

Link to text

 

Text:

Torres HA et al, Hepatology. 2018;67(1):36-47

Hepatitis C virus (HCV) and cancer treatment: HCV reactivation is common in patients receiving rituximab or high-dose steroids, however, most patients experience no clinical problems. Thus, HCV infection is no contraindication for cancer treatment. Patients receiving rituximab or high-dose steroids should be monitored closely.

Link to text

Text:

Kim GA et al, J Hepatol. 2018;68(1):140-6

Non-alcoholic fatty liver disease (NAFLD): NAFLD is associated with development of hepatocellular carcinoma, colorectal cancer in males and breast cancer in females. Risk predictors are high values in the NAFLD fibrosis score and the fibrosis-4 score.

Link to text

 

Oesophagus Stomach Duodenum

Text:

Katzka DA et al, Am J Gastroenterol. 2017;112(10):1538-44

Monitoring of disease activity in eosinophilic esophagitis (EoE): Comparative trial with endoscopy demonstrates that the cytosponge system, is a minimally invasive, safe, well tolerated and accurate method to assess EoE histologic activity.

Link to text

 

Text:

Kang YK et al, Lancet. 2017;390(10111):2461-71

Immune therapy for advanced gastric or gastroesophageal junction cancer: The PD-1 antibody Nivolumab results in significant survival benefits in patients after failure or intolerance of 2 lines of standard chemotherapy.

Link to text

 

Text:

Bomme M et al, Clin Gastroenterol Hepatol. 2017;15(11):1715-23.e7

Effects of community screening for Helicobacter pylori in a low-prevalence area: Randomized trial with 13 years of follow-up showed no significant effect of screening/eradication of H. pylori on the prevalence of dyspeptic symptoms, incidence of ulcer disease and quality of life, as compared to usual care.

Link to text

 

Pancreas

Text:

van Brunschot S et al, Lancet. 2018;391(10115):51-8

Endoscopic or surgical step-up approach for infected necrotizing pancreatitis: Endoscopic therapy is not superior to surgery in reducing major complications or death. However, the rate of pancreatic fistulas and length of hospital stay were lower in the endoscopy group.

Link to text

 

International Symposia and Workshops

Symposium 210

Crossing New Borders in IBD: Thoughts and Demands – From Mechanisms to Treatment

April 20 – 21, Lisbon, Portugal
Estoril Centro de Congressos, Avenida Amaral, 2765-192 Estoril, Portugal

Program

 

Registration

 

Online registration

 
Symposium 211

XXV International Bile Acid Meeting: Bile Acids in Health and Disease 2018

July 6-7, 2018, Dublin, Ireland
Clayton Hotel Burlington Road, Upper Leeson Street, D04 A318 Dublin 4, Ireland

Program

 

Registration

 

Online registration

 

Current Falk literature:

Azathioprine in daily practice
The basic principle of immunosuppressive therapy
Guidance for practical use in gastroenterology and hepatology
Author: J. Weismüller
(41 pages)
Az8e

PDF download